- Q1 2024 Embla Medical hf Earnings Call TranscriptApr 23, 2024kr30.7 (+1.99%)Earnings
- Q4 2023 Ossur hf Earnings Call TranscriptJan 30, 2024kr29.65 (+4.40%)Earnings
- Q3 2023 Ossur hf Earnings Call TranscriptOct 24, 2023kr29.3 (+2.99%)Earnings
- Q2 2023 Ossur hf Earnings Call TranscriptJul 25, 2023kr32.4 (+1.73%)Earnings
- Q1 2023 Ossur hf Earnings Call TranscriptApr 25, 2023kr30.75 (-1.76%)Earnings
- Ossur hf Corporate Analyst Meeting TranscriptMar 30, 2023
- Q4 2022 Ossur hf Earnings Call TranscriptJan 31, 2023Earnings
- Q3 2022 Ossur hf Earnings Call TranscriptOct 25, 2022kr32.95 (-1.79%)Earnings
- Q2 2022 Ossur hf Earnings Call TranscriptJul 21, 2022kr31.5 (+5.00%)Earnings
- Preliminary Q2 2022 Ossur hf Earnings Call TranscriptJul 18, 2022kr29.6Earnings
- Q1 2022 Ossur hf Earnings Call TranscriptApr 26, 2022kr36.4 (-5.45%)Earnings
- Q4 2021 Ossur hf Earnings Call TranscriptFeb 01, 2022kr40.6 (+4.10%)Earnings
- Q3 2021 Ossur hf Earnings Call TranscriptOct 26, 2021kr43.2Earnings
- Q2 2021 Ossur hf Earnings Call TranscriptJul 22, 2021kr48 (+1.27%)Earnings
- Q1 2021 Ossur hf Earnings Call TranscriptApr 27, 2021kr47.25 (+2.05%)Earnings
- Q4 2020 Ossur hf Earnings Call TranscriptFeb 02, 2021kr46.25 (+0.22%)Earnings
- Q3 2020 Ossur hf Earnings Call TranscriptOct 27, 2020kr42 (-2.33%)Earnings
- Q2 2020 Ossur hf Earnings Call TranscriptJul 23, 2020kr44.3 (+0.23%)Earnings
- Q1 2020 Ossur hf Earnings Call TranscriptApr 30, 2020kr43.65 (+1.51%)Earnings
- Q4 2019 Ossur hf Earnings Call TranscriptFeb 04, 2020kr49.55 (-0.10%)Earnings
- Full Year 2019 Ossur hf Guidance Call TranscriptJan 14, 2020
- Q3 2019 Ossur hf Earnings Call TranscriptOct 22, 2019kr45.5 (+1.11%)Earnings
- Q2 2019 Ossur hf Earnings Call TranscriptJul 25, 2019kr45.95 (+5.88%)Earnings
- Q1 2019 Ossur hf Earnings Call TranscriptApr 30, 2019kr37.3 (+5.97%)Earnings
Q2 2021 Ossur hf Earnings Call Transcript
Ladies and gentlemen, welcome to the Ãssur's Q2 2021 Results. Today, I am pleased to present Mr. Jon Sigurdsson, President and CEO; and Mr. Sveinn Solvason, CFO. (Operator Instructions)
Speakers, please begin.
&
Yes. I would like to thank -- I would like to welcome you to Ãssur investor conference call where we will cover the results for the second quarter of 2021. My name is Jon Sigurdsson, as previously mentioned, and I'm the President and CEO. And with me here today is Sveinn Solvason, our CFO. We will begin by going through the highlight of the quarter and ending with our guidance on 2021. A question-and-answer session will then follow.
Sales in the second quarter of 2021 amounted to $190 million, which correspond to 32% organic growth. The sales growth is high in Q2 as the comparison quarter was the most affected by COVID-19 last year. Sales continued to normalize in our key market, both in prosthetics and bracing & supports. The impact from
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)